Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 29, 2020
Trimethoprim-sulfamethoxazole Versus Azithromycin for the Treatment of Undifferentiated Febrile Illness in Nepal: A Double-blind, Randomized, Placebo-controlled TrialAbhishek Giri, Abhilasha Karkey, Sabina Dangol, et al.
Indian Journal of Critical Care Medicine : Peer-Reviewed, Official Publication of Indian Society of Critical Care Medicine|March 25, 2020
Indian Society of Critical Care Medicine Position Statement for Central Venous Catheterization and Management 2020Yash Javeri, Ganshyam Jagathkar, Subhal Dixit, et al.
Antimicrobial Agents and Chemotherapy|September 15, 2010
Suitable disk antimicrobial susceptibility breakpoints defining Salmonella enterica serovar Typhi isolates with reduced susceptibility to fluoroquinolonesChristopher M Parry, Chau Tran Thuy, Sabina Dongol, et al.
The Lancet. Infectious Diseases|January 27, 2016
Gatifloxacin versus ceftriaxone for uncomplicated enteric fever in Nepal: an open-label, two-centre, randomised controlled trialAmit Arjyal, Buddha Basnyat, Ho Thi Nhan, et al.
Wellcome Open Research|February 1, 2022
Azithromycin and cefixime combination versus azithromycin alone for the out-patient treatment of clinically suspected or confirmed uncomplicated typhoid fever in South Asia: a randomised controlled trial protocolAbhishek Giri, Abhilasha Karkey, Sabina Dongol, et al.
Nature Genetics|November 11, 2014
Variation at HLA-DRB1 is associated with resistance to enteric feverSarah J Dunstan, Nguyen Thi Hue, Buhm Han, et al.
Antimicrobial Agents and Chemotherapy|October 3, 2007
Antimicrobial drug resistance of Salmonella enterica serovar typhi in asia and molecular mechanism of reduced susceptibility to the fluoroquinolonesTran Thuy Chau, James Ian Campbell, Claudia M Galindo, et al.
Pageof 8